Paradoxical amphetamine effect in hyperactive rats in relation to norepinephrine metabolism.
D000596:Amino Acids / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002713:Chlorine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000378:metabolism; D010649:Phenylalanine / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014316:Tritium
D000596:Amino Acids; D011807:Quinolizines; D011748:Pyrogallol; D009647:Normetanephrine; D014316:Tritium; D012701:Serotonin; D010649:Phenylalanine; D002713:Chlorine; D000661:Amphetamine; D007490:Iproniazid; D008995:Monoamine Oxidase; D003042:Cocaine; D003891:Desipramine; D009638:Norepinephrine